Abstract
The use of nanoemulsions as a carrier system for skin targeting has attracted increased attention over recent years. Nanoemulsions can be intended for both topical and systemic delivery of the biologically active agents for controlled and targeted delivery. Nanoemulsion droplets fall within the size range of 20-200nm, typically below 100nm. Nanoemulsions have high surface area and ability to solubilize poorly soluble drugs. They are reported to have higher skin permeation and retention potential than other novel drug delivery systems like nanoparticles, liposomes, microemulsions etc. Use of nanoemulsions for skin targeting of drug is a current research scenario in the field of Pharmaceutics. This research area has generated immense interest from the Pharmaceutical industry and a number of nanoemulsion based cosmetics formulations like anti-aging creams, skin cleansing lotions etc. are available in the market. Recently, Zydus Cadilla launched the Oxalgin NanoGel™ diclofenac sodium nanoemulsion gel showing the importance of nanoemulsion as carrier system for skin targeting of drugs. This review embodies an in-depth discussion on composition, application, its mechanism of skin permeation and commercial aspects of nanoemulsions for skin targeting.
Keywords: Anti-acne, skin targeting, nanoemulsion, NSAIDs, commercial products, anti-fungal, anti-cancer, TOPICAL DELIVERY, Anti-Cancer Drugs
Drug Delivery Letters
Title: Nanoemulsions for Skin Targeting: Present Status and Future Prospects
Volume: 1 Issue: 2
Author(s): Mukta Singh and Subheet Jain
Affiliation:
Keywords: Anti-acne, skin targeting, nanoemulsion, NSAIDs, commercial products, anti-fungal, anti-cancer, TOPICAL DELIVERY, Anti-Cancer Drugs
Abstract: The use of nanoemulsions as a carrier system for skin targeting has attracted increased attention over recent years. Nanoemulsions can be intended for both topical and systemic delivery of the biologically active agents for controlled and targeted delivery. Nanoemulsion droplets fall within the size range of 20-200nm, typically below 100nm. Nanoemulsions have high surface area and ability to solubilize poorly soluble drugs. They are reported to have higher skin permeation and retention potential than other novel drug delivery systems like nanoparticles, liposomes, microemulsions etc. Use of nanoemulsions for skin targeting of drug is a current research scenario in the field of Pharmaceutics. This research area has generated immense interest from the Pharmaceutical industry and a number of nanoemulsion based cosmetics formulations like anti-aging creams, skin cleansing lotions etc. are available in the market. Recently, Zydus Cadilla launched the Oxalgin NanoGel™ diclofenac sodium nanoemulsion gel showing the importance of nanoemulsion as carrier system for skin targeting of drugs. This review embodies an in-depth discussion on composition, application, its mechanism of skin permeation and commercial aspects of nanoemulsions for skin targeting.
Export Options
About this article
Cite this article as:
Singh Mukta and Jain Subheet, Nanoemulsions for Skin Targeting: Present Status and Future Prospects, Drug Delivery Letters 2011; 1 (2) . https://dx.doi.org/10.2174/2210304x11101020159
DOI https://dx.doi.org/10.2174/2210304x11101020159 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Approaches to Immunotherapy in Non-Small Cell Lung Cancer: Current and Future Perspectives
Current Molecular Pharmacology Adenosine A<sub>3</sub> Receptor: A promising therapeutic target in cardiovascular disease
Current Cardiology Reviews Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma
Current Cancer Drug Targets Streamlined In Vivo Selection and Screening of Human Prostate Carcinoma Avid Phage Particles for Development of Peptide Based In Vivo Tumor Imaging Agents
Combinatorial Chemistry & High Throughput Screening Resveratrol as an Enhancer of Apoptosis in Cancer: A Mechanistic Review
Anti-Cancer Agents in Medicinal Chemistry Mevalonate Kinase Deficiency: Disclosing the Role of Mevalonate Pathway Modulation in Inflammation
Current Pharmaceutical Design Subject Index to Volume 7
Combinatorial Chemistry & High Throughput Screening Are Selenoproteins Important for the Cancer Protective Effects of Selenium?
Current Nutrition & Food Science A Novel Information Theoretic Approach to Gene Selection for Cancer Classification Using Microarray Data
Current Bioinformatics Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer
Current Pharmaceutical Design Thymic Nurse Cells Participate in Heterotypic Internalization and Repertoire Selection of Immature Thymocytes; Their Removal from the Thymus of Autoimmune Animals May be Important to Disease Etiology
Current Molecular Medicine Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Cardiovascular & Hematological Agents in Medicinal Chemistry Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Biotechnology Cancer Chemoprevention Drug Targets
Current Drug Targets A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets Next Generation Sequencing in the Management of Leptomeningeal Metastases of Non-Small Cell Lung Cancer: A Case Report and Literature Review
Recent Patents on Anti-Cancer Drug Discovery Ornithine Decarboxylase Inhibition: A Strategy to Combat Various Diseases
Mini-Reviews in Medicinal Chemistry Tackling Cardiovascular Risk: New Evidence from Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Tamoxifen in the Treatment of Hepatocellular Carcinoma: 5-Year Results of the CLIP-1 Multicentre Randomised Controlled Trial
Current Pharmaceutical Design Antitumor Potential and Possible Targets of Phenothiazine-Related Compounds
Current Drug Targets